Kevzara/Sarilumab STUDY HALTED-No benefit seen... this will be the same for all IL6 blockers / arthritis medications... they don't even do that good of a job there, and secondary infections are rampant. Friend of mine in the ICU was in this study, currently with... you guessed it: bacterial infection.

https://www.wsj.com/articles/drug-study-halte...1587985203

Will be the same story for Actrema / Tocilizumab, with little doubt:

https://www.rheumatologyadvisor.com/home/topi...mab-in-ra/